lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis
Frontiers of Medicine · 2024
DOI: 10.1007/s11684-024-1065-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers of Medicine, 2024. Verfasst von Tong Yu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai Univ…. Hauptthemen laut MEDLINE: Cardiomegaly, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, RNA, Long Noncoding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai University of Engineering Science, Shanghai, 201620, China.
- Department of Physiology, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China.
- State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Educa…
- Department of Physiology, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China. lvlifanggaoqiang@163.com.
- The Center of Functional Experiment Teaching, School of Basic Medicine, Harbin Medical University, Harbin, 150081, China. lvlifanggaoqiang@163.com.
- Shanghai Frontiers Science Research Center for Druggability of Cardiovascular Noncoding RNA, Institute for Frontier Medical Technology, Shanghai University of Engineering Science, Shanghai, 201620, China. shanhl@sues.ed…
Zitieren
APA
Yu, T., Gao, Q., Zhang, G., Li, T., Liu, X., Li, C., Zheng, L., Sun, X., Wu, J., Cao, H., Bi, F., Wang, R., Liang, H., Li, X., Zhou, Y., Lv, L., & Shan, H. (2024). lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1065-7
Vancouver
Yu T, Gao Q, Zhang G, Li T, Liu X, Li C, et al. lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis. Frontiers of Medicine. 2024. doi:10.1007/s11684-024-1065-7
BibTeX
@article{Yu2024,
author = {Yu, Tong and Gao, Qiang and Zhang, Guofang and Li, Tianyu and Liu, Xiaoshan and Li, Chao and Zheng, Lan and Sun, Xiang and Wu, Jianbo and Cao, Huiying and Bi, Fangfang and Wang, Ruifeng and Liang, Haihai and Li, Xuelian and Zhou, Yuhong and Lv, Lifang and Shan, Hongli},
title = {lncRNA Gm20257 alleviates pathological cardiac hypertrophy by modulating the PGC-1α–mitochondrial complex IV axis},
journal = {Frontiers of Medicine},
year = {2024},
doi = {10.1007/s11684-024-1065-7}
}
EUVIMED